» Articles » PMID: 34683124

Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells

Overview
Journal J Pers Med
Date 2021 Oct 23
PMID 34683124
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

: CRISPR/Cas9 system is a prokaryotic adaptive immune response system that uses noncoding RNAs to guide the Cas9 nuclease to induce site-specific DNA cleavage. Hepatocyte growth factor (HGF) is a well-known growth factor that plays a crucial role in cell growth and organ development. According to recent studies, it has been reported that HGF promoted growth of hepatocellular carcinoma (HCC) cells. Here, we investigated the apoptotic effects in HCC cells. Crispr-HGF plasmid was constructed using GeneArt CRISPR Nuclease Vector. pMex-HGF plasmid that targets HGF overexpressing gene were designed with pMex-neo plasmid. We performed real time-polymerase chain reaction to measure the expression of HGF mRNA. We performed cell counting assay and colony formation assay to evaluate cell proliferation. We also carried out migration assay and invasion assay to reveal the inhibitory effects of Crispr-HGF in HCC cells. Furthermore, we performed cell cycle analysis to detect transfection of Crispr-HGF induced cell cycle arrest. Collectively, we performed annexin V/PI staining assay and Western blot assay. In Crispr-HGF-transfected group, the mRNA expression levels of HGF were markedly downregulated compared to pMex-HGF-transfected group. Moreover, Crispr-HGF inhibited cell viability in HCC cells. We detected that wound area and invaded cells were suppressed in Crispr-HGF-transfected cells. The results showed that transfection of Crispr-HGF induced cell cycle arrest and apoptosis in HCC cells. Expression of the phosphorylation of mitogen activated protein kinases and c-Met protein was regulated in Crispr-HGF-transfected group. Interestingly, we found that the expression of HGF protein in conditioned media significantly decreased in Crispr-HGF-transfected group. Taken together, we found that inhibition of HGF through transfection of Crispr-HGF suppressed cell proliferation and induced apoptotic effects in HCC Huh7 and Hep3B cells.

Citing Articles

Current Landscape and Future Directions in Cancer Immunotherapy: Therapies, Trials, and Challenges.

Bandara S, Raveendran S Cancers (Basel). 2025; 17(5).

PMID: 40075668 PMC: 11899461. DOI: 10.3390/cancers17050821.


CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma.

Palaz F, Ozsoz M, Zarrinpar A, Sahin I J Hepatocell Carcinoma. 2024; 11:975-995.

PMID: 38832119 PMC: 11146628. DOI: 10.2147/JHC.S456683.


A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.

Amjad E, Pezzani R, Sokouti B Oncol Res. 2024; 32(3):439-461.

PMID: 38361756 PMC: 10865741. DOI: 10.32604/or.2023.044473.


Ten Years of CRISPRing Cancers In Vitro.

Capoferri D, Filiberti S, Faletti J, Tavani C, Ronca R Cancers (Basel). 2022; 14(23).

PMID: 36497228 PMC: 9738354. DOI: 10.3390/cancers14235746.


Enhanced Myogenesis by Silencing Myostatin with Nonviral Delivery of a dCas9 Ribonucleoprotein Complex.

Chen Y, Banie L, Breyer B, Tan Y, Wang Z, Zhou F CRISPR J. 2022; 5(4):598-608.

PMID: 35758824 PMC: 9419946. DOI: 10.1089/crispr.2022.0009.


References
1.
Lee C, Choi Y, Park S, Nam M . Indole-3-carbinol induces apoptosis in human hepatocellular carcinoma Huh-7 cells. Food Chem Toxicol. 2018; 118:119-130. DOI: 10.1016/j.fct.2018.05.014. View

2.
Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E . Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 2006; 12(45):7239-49. PMC: 4087479. DOI: 10.3748/wjg.v12.i45.7239. View

3.
Akram F, Ul Haq I, Ahmed Z, Khan H, Ali M . CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review. Protein Pept Lett. 2020; 27(10):931-944. DOI: 10.2174/0929866527666200407112432. View

4.
Breunig C, Erdem N, Bott A, Greiwe J, Reinz E, Bernhardt S . TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer. Mol Oncol. 2018; 12(9):1447-1463. PMC: 6120235. DOI: 10.1002/1878-0261.12355. View

5.
Kang M, Jeon Y, Nam M . Auricularia auricula increases an apoptosis in human hepatocellular carcinoma cells via a regulation of the peroxiredoxin1. J Food Biochem. 2020; 44(10):e13373. DOI: 10.1111/jfbc.13373. View